Financial News
All News about Aileron Therapeutics, Inc. - Common Stock
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_6306.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_3986.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/21/image24.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/21/image14.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/21/alrn_logo_light__fe1fe357300c618d6ff9411bf9a464e2.png?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 21, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/21/image38.jpeg?width=1200&height=800&fit=crop)
Dow Tumbles More Than 500 Points; US Manufacturing PMI Rises In February
February 21, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/21/image-walmart.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/0f820a8e-3c6b-47d8-bbd1-78d7a9ae490d/small/aileron-logo-png.png)
![](https://ml.globenewswire.com/media/0f820a8e-3c6b-47d8-bbd1-78d7a9ae490d/small/aileron-logo-png.png)
Aileron Therapeutics Regains Compliance with Nasdaq Listing Requirements
November 30, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0f820a8e-3c6b-47d8-bbd1-78d7a9ae490d/small/aileron-logo-png.png)
![](https://ml.globenewswire.com/media/0f820a8e-3c6b-47d8-bbd1-78d7a9ae490d/small/aileron-logo-png.png)
![](https://ml.globenewswire.com/media/0f820a8e-3c6b-47d8-bbd1-78d7a9ae490d/small/aileron-logo-png.png)
![](https://ml.globenewswire.com/media/0f820a8e-3c6b-47d8-bbd1-78d7a9ae490d/small/aileron-logo-png.png)
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17340.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/15/image_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_15579.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/09/image_3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14277.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/08/image46.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14215.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/05/image_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13723.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/03/image30.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13860.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/02/image-applied-dna-sciences.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/02/image-revlon.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13755.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/15/image11_0.jpg?width=1200&height=800&fit=crop)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.